Thousands of women whose breast cancer has become resistant to standard treatment could benefit from a new drug combination .
It is hoped the new approach will target cancer stem cells that evade conventional drugs and cause the tumour to re-grow .
Cancer that has spread and is incurable , known as secondary breast cancer kills 1,000 women in Britain .
Researchers from Manchester University have developed a new combination of drugs .